BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33565764)

  • 21. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
    Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
    Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
    Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
    Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
    Kumar S; Raza M; Tariq MU
    J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
    Eichhorn JH; Young RH; Clement PB; Scully RE
    Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed Müllerian Tumors of the Female Genital Tract.
    Soslow RA
    Surg Pathol Clin; 2009 Dec; 2(4):707-30. PubMed ID: 26838776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corded and Hyalinized and Spindled Endometrioid Endometrial Carcinoma: A Clinicopathologic and Molecular Analysis of 9 Tumors Based on the TCGA Classifier.
    Safdar NS; Thompson EF; Gilks CB; Isacson C; Bennett JA; Clarke B; Young RH; Oliva E
    Am J Surg Pathol; 2021 Aug; 45(8):1038-1046. PubMed ID: 34115671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
    Seagle BL; Kanis M; Strohl AE; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-radiation Mullerian adenosarcoma with sarcomatous overgrowth: rare presentation of an uncommon malignancy.
    Mubeen A; Shahid M; Makary R
    Pathologica; 2020 Dec; 112(4):219-223. PubMed ID: 33393526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-grade metaplastic adenocarcinoma (carcinosarcoma) of the uterus: report of an unusual case.
    Zamecnik M; Sokol L; Michal M
    Ann Diagn Pathol; 2005 Dec; 9(6):335-9. PubMed ID: 16308164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
    Bell KA; Kurman RJ
    Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
    Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
    Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine polyps with features overlapping with those of Müllerian adenosarcoma: a clinicopathologic analysis of 29 cases emphasizing their likely benign nature.
    Howitt BE; Quade BJ; Nucci MR
    Am J Surg Pathol; 2015 Jan; 39(1):116-26. PubMed ID: 25118811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
    Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
    Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
    de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
    Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.